GLIS1 Antibodies

Santa Cruz Biotechnology delivers a wide array of GLIS1 monoclonal antibodies for research focused on understanding GLIS1's role in various biological processes. GLIS1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GLIS1, or GLI-similar 1, is a transcription factor that plays a crucial role in regulating gene expression during development and cellular differentiation. GLIS1 functions within various signaling pathways, including the Hedgehog signaling pathway, and influences processes such as cell proliferation and tissue homeostasis. Research has shown GLIS1's involvement in multiple cellular mechanisms that impact both normal development and disease progression. Scientists studying GLIS1 can gain valuable insights into its potential role in cancer and developmental disorders. Understanding GLIS1's molecular mechanisms and cellular functions continues to advance knowledge in developmental biology and disease research. GLIS1 monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance scientific understanding of cellular processes and disease mechanisms.